Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Panelists discuss how trial findings for aflibercept 8 mg and faricimab in RVO demonstrate comparable efficacy and durability ...

Panelists discuss how pivotal RVO trial data for aflibercept 8 mg show strong durability and visual outcomes while raising ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...

Chris R. Alabiad, MD: There wasn’t one single national rule change in 2025 that transformed residency training overnight.

Ophthalmology conferences are often remembered not just for scientific sessions or new technologies, but for the personal ...

Looking back on 2025, Neda Shamie shares how a challenging monocular patient reinforced the importance of patience, presence, ...

From artificial intelligence to home monitoring, Joel Schuman, MD, of Wills Eye Hospital, explores the innovations that could ...

Panelists discuss how faricimab and aflibercept 8 mg compare in drying and durability and how clinicians manage IOP ...

Panelists discuss how real-world adherence to loading doses and thoughtful switching or reloading strategies can optimize ...

Over the past decade, earning an ophthalmology residency spot has become more difficult and competitive. 1 Between 2021 and ...